GTR Home > Genes

ALK ALK receptor tyrosine kinase

Gene ID: 238, updated on 18-Sep-2024
Gene type: protein coding
Also known as: ALK1; CD246; NBLST3

Summary

This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]

Copy number response

Description
Copy number response
Haploinsufficency

No evidence available (Last evaluated 2019-12-20)

ClinGen Genome Curation Page
Triplosensitivity

No evidence available (Last evaluated 2019-12-20)

ClinGen Genome Curation Page

Genomic context

Location:
2p23.2-p23.1
Sequence:
Chromosome: 2; NC_000002.12 (29192774..29921586, complement)
Total number of exons:
29

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.